PDL BioPharma Inc (NASDAQ:PDLI)
| 9.48 Data as of Jul 29 |  +0.005 / +0.05%Today’s Change | 7.38 Today|||52-Week Range 10.21 | +12.26% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Operating Activities | Net Income / Starting Line | 91.9M | 199.4M | 211.7M | 264.5M | |
| Depreciation | 330.0K | 1.4M | 946.0K | 5.6M | ||
| Total Other Cash Flow | 27.1M | 11.0M | 14.4M | 13.8M | ||
| Funds From Operations | 113.7M | 243.0M | 238.3M | 282.9M | ||
| Funds From/For Other Operating Expenses | -70.6M | 73.2M | 28.1M | 12.0M | ||
| Net Cash Flow - Operating Activities | 184.3M | 169.8M | 210.2M | 270.9M | ||
| Investing | Increase In Investments | -46.7M | -74.7M | -125.2M | -9.9M | |
| Decrease In Investments | 9.8M | 50.7M | 50.8M | 43.8M | ||
| Capital Expenditures | 0.00 | 0.00 | -51.0K | -2.0K | ||
| Other Investing - Uses | 0.00 | 0.00 | 0.00 | -148.7M | ||
| Other Investing - Sources | 0.00 | 0.00 | 5.0M | 58.1M | ||
| Net Cash Flow Investing | -36.9M | -24.0M | -69.4M | -298.0M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -93.4M | 74.2M | |
| Long Term Borrowings | 82.0M | 149.7M | -845.0K | 0.00 | ||
| Long Term Debt Reduction | -204.0M | -244.8M | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 0.00 | 10.9M | 0.00 | 0.00 | ||
| Common Preferred Redeemed | 0.00 | -20.8M | 0.00 | 0.00 | ||
| Common Dividends | -130.0M | -83.8M | -83.9M | -84.0M | ||
| Cash Dividends Paid - Total | -130.0M | -83.8M | -83.9M | -84.0M | ||
| Other Sources - Financing | 12.9M | 0.00 | 27.0K | 22.0K | ||
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -239.1M | -188.8M | -178.1M | -9.8M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | 0.00 | 0.00 | -- |
| Net Change In Cash | -91.7M | -43.0M | -37.3M | -36.9M | ||
.
